Level C· Early human research exploring benefitsProspective StudyEurope PMC

The regeneration of organogenesis

Soto-Gutierrez A., Wertheim JA.

Prospective Study, published in Organogenesis (2013) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
Organogenesis (2013)
Reported sample size
—
Source database
Europe PMC
PMID
23594929
PMCID
PMC3674033
DOI
10.4161/org.24545
Citations
1

Abstract (original English)

We would like to welcome our readers to the regenerated Organogenesis and to share with you the reasoning behind the refocusing of this journal toward the development of tissues and organs as a future means to improve the health of patients.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansTissue EngineeringDevelopmental BiologyRegenerative MedicineOrganogenesisPeriodicals as Topic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.